Loading Events

« All Events

Greenfield Memorial Lecture: Progress in Suicide Prevention | Charles B. Nemeroff, MD, PhD

September 12 @ 5:00 pm - 7:00 pm

Progress in Suicide Prevention

THURSDAY, SEPTEMBER 12, 2019
5:30 – 7:00PM

Wisconsin Psychiatric Institute and Clinic
6001 Research Park Boulevard, Room 1616
* Light refreshments will be served *

Charles B. Nemeroff, MD, PhD
Professor and Acting Chair
Department of Psychiatry
Associate Chair for Research
Director, Institute of Early Life Adversity Research
Dell Medical School, The University of Texas at Austin

Suicide is the 10th leading cause of death in the United States, the only one of the top ten that is increasing in number year after year. This year there will likely be 50,000 suicides in the United States (130 per day) and in addition approximately 20,000 of the 70,000 opiate overdose deaths each year are classified as suicides. It is the second leading cause of death in the 15-34 year age group. In spite of many public health and education efforts in the past decade, suicide rates have continued to climb. Research on risk factors for suicide have been informative.  Men are at significantly greater risk for suicide than women. In addition other risk factors that have been clearly documented are a past diagnosis of depression or related psychiatric disorders,  history of childhood maltreatment including bullying, family history of suicide (underlying the genetic component of risk), alcohol and substance abuse, as well as more recent life stressors such as loss of job, a recent serious medical diagnosis, imminent divorce and recent trauma. The reduction of available psychiatric inpatient beds is also associated with the year over year increase nationally. There is considerable evidence for an underlying neurobiological basis for suicidality including increased inflammation, decreased activity of serotonergic circuits in the brain and increase activity of the major mammalian stress system, the pituitary-adrenal axis. Certain medications including lithium and clozapine are known to reduce suicide as are  certain forms of cognitive-behavioral therapy (CBT). Finally providing obstacles to means of suicide has been shown to be effective in reducing suicide rates.

 

Details

Date:
September 12
Time:
5:00 pm - 7:00 pm

Organizer

Amber Sebastian
Phone:
(608)263-0491
Email:
sebastian@wisc.edu

Venue

WisPIC Commons Room 1616
6001 Research Park Blvd - Room 1616
Madison, WI 53719
+ Google Map